REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

DV Biomed Co., Ltd. (Taiwan, China)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: DV Biomed Co., Ltd. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

UnicoCell Biomed Co., Ltd. specializes in the study of adipose stem cells for disease and anti-aging. The company was founded in 2011 and located in Taipei City. .

Headquarters
6F., No.63, Ln77, Xing Ai Rd., Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the DV Biomed Co., Ltd. report to view the information.

Website: http://www.unicocell.com

Basic Information
Total Employees:
Purchase the DV Biomed Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the DV Biomed Co., Ltd. report to view the information.
Financial Auditors:
Purchase the DV Biomed Co., Ltd. report to view the information.
Incorporation Date:
June 21, 2011
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
35.63%
Purchase this report to view the information.
9.05%
Purchase this report to view the information.
8.6%
Purchase this report to view the information.
0.04%
Purchase this report to view the information.
Subsidiaries
Goodeal Enterprises Limited (United Kingdom)
100%
Company Performance
Financial values in the chart are available after DV Biomed Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-69.42%▼
Total operating revenue
-69.35%▼
Operating profit (EBIT)
-78.71%▼
EBITDA
-83.79%▼
Net Profit (Loss) for the Period
-77.63%▼
Total assets
-68.99%▼
Total equity
-55.7%▼
Operating Profit Margin (ROS)
-5.45%▼
Net Profit Margin
-4.13%▼
Return on Equity (ROE)
-5.49%▼
Quick Ratio
2.85%▲
Cash Ratio
1.78%▲

Similar companies

Syngen Biotech Co., Ltd.
 
CH Biotech R&D Co., Ltd.
Medigen Biotechnology Corporation
 
EirGenix Inc.
Glac Biotech Co., Ltd. (Tainan City) (丰华生物科技 (台南市))
 
Avita Corporation
Ever Supreme Bio Technology Co., Ltd.
 
Level Biotechnology Inc.
Kim Forest Enterprise Co., Ltd.
 
Medigen Vaccine Biologics Corporation

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo